Those who follow my columns will know that I am in the habit of starting with reminiscences. It’s something that …

Although my specialism for the last 35 years has been clinical research, I actually started in the pharmaceutical industry as …
The question of ‘generalisability’ – or the extent clinical trials can be applied to the real world, has been an …
Ofichem acquires US drug substance CDMO Kinentia
Jager-van Dijk is new Arletta Pharma Solutions CEOÂ
Tridem begins phase Ib trial of Parkinson’s disease vaccine

